CLLS

Cellectis S.A.

1 day chart

About CLLS

Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Buy US stocks in Australia starting with CLLS. Open an account and start investing today!

Market Capitalisation

$104.73M

Price-earnings ratio

Dividend yield

0.00%

Volume

20.92K

High today

$1.89

Low today

$1.80

Open price

$1.81

52-week high

$4.10

52-week low

$1.68

CLLS FAQs

Can I buy CLLS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy CLLS shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Cellectis S.A.?

One share of Cellectis S.A. is valued at $1.83.

What is the ticker symbol for Cellectis S.A.?

The ticker symbol for Cellectis S.A. is CLLS.

How do I buy CLLS shares in Australia?

To buy CLLS stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in CLLS

What is the 52-week high for Cellectis S.A. stock?

The Cellectis S.A. 52-week high stock price is $4.10.

What is the 52-week low for Cellectis S.A. stock?

The Cellectis S.A. 52-week low stock price is $1.68.

What is the market capitalisation of Cellectis S.A. CLLS?

As of 27/05/2023 Cellectis S.A. has a market cap of $105M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.